BIOspektrum - the Offical Newsletter of VBU
|
On the VBU website, VBU members can report on cutting-edge, innovative technologies in other sections of the journal after consultation with the publisher.Board Member
VBU Board Member |
|
| in brief: | |
|
Dr. Uwe Gottschalk
Vice President Purification Technologies |
|
|
Sartorius Stedim Biotech GmbH August-Spindler-Straße 11 37079 Göttingen |
|
| Born | 23.10.1961 | |
| Education: | ||
|
1990 |
Dr. rer. nat. University of Münster | |
|
1991 |
Biochemistry; Projects of the Commission of the European Community | |
|
Work Experience:
|
|
|
|
Since 2004
|
Sartorius Stedim Biotech Vice President Purification Technologies |
|
|
1999 - 2004
|
Bayer Health Care Head of the GMP Protein Purification Facility, Wuppertal |
|
| 1991 - 1999 |
Bayer Health Care Protein Purification Manager, Bayer Pharma-Biotechnology |
|
| Responsibility: |
|
|
|
Dr. Uwe Gottschalk is Group Vice President Purification Technologies with a global responsibility for bioseparation products. He has various publications in the areas of biotechnology and somatic gene therapy, and is Head Lecturer at the University of Essen (Germany) and Lecturer at the EPFL in Lausanne (Switzerland). Sartorius is an internationally leading laboratory and process technology provider with areas of core competence in biotechnology and mechatronics. |
||
|
||